Systemic lupus erythematosus. Current treatment.
DOI:
https://doi.org/10.20344/amp.4136Abstract
The treatment of the systemic lupus erythematosus (S.L.E.) has been modified significantly during the last years, contributing decisively to a better prognosis, and an increase in the life expectancy of patients. In this issue of the Acta Médica Portuguesa, we divulge our personal experience; the most recent advances in the treatment of this disease and, also, some future therapeutic perspectives.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
